Integrative Analysis of Tumor Microenvironment and Optimization of Immunotherapy Duration in NSCL Cancer Patients

NCT04880382 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Enrolment was slowlier than expected.

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: ICI treatment discontinuation
DRUG: ICI treatment continuation

Sponsor

Institut Bergonié